← Return to Aromatase Inhibitors: Did you decide to go on them or not?

Discussion

Aromatase Inhibitors: Did you decide to go on them or not?

Breast Cancer | Last Active: May 12, 2023 | Replies (1190)
Comment receiving replies
@songsparrow

My tumor met all of these criteria, so it makes sense that he didn’t do the oncotype test. It was 7mm, grade 1, 98% ER+, HER2-. I didn’t know what an oncotype even was, but I have seen so many others reference it when they talked about their cancer. Thank you for explaining!

Jump to this post

Replies to "My tumor met all of these criteria, so it makes sense that he didn’t do the..."
windyshores | @windyshores | Feb 8, 2023

That is good news for you!

https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e12043

"Conclusions: This retrospective analysis suggests that 97% of patients with T1b, grade 1, ER/PR positive, HER-2 negative breast cancers had Oncotype scores of less than 25. Hence Oncotype testing may be safely omitted for this group. Grade along with Ki 67 can identify a subset of T1bN0 ER/PR positive and Her 2 negative patients who do not need Oncotype testing."

VIEW AND REPLY